Whether iRBD patients with high concentrations of α-synuclein aggregates in stool are more likely to convert faster to PD, DLB, or MSA, or are more likely to develop a particular type of synucleinopathy remains to be determined. This evidence concerns the gene SNCA and Parkinson disease.